Chancery Hits Hedge Fund With Sanctions In Bioverativ Case
By Jeff Montgomery ( January 26, 2024, 8:48 PM EST) -- An activist hedge fund principal and four affiliated funds were hit with hefty Delaware Chancery Court pretrial sanctions Friday for unexplained loss or deletion of electronic messages sought for a stockholder challenge to Sanofi's $11.6 billion acquisition of biomedical venture Bioverativ....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.